Back to today’s briefing

Story perspectives

Eubiologics Secures $108M Deal to Combat Cholera Vaccines

2/13/2025

33 3

Summary

Story summary

Korean company Eubiologics is stepping up to combat cholera, clinching a $108.3 million deal with UNICEF to supply 72 million vaccines by 2025. In response to a pressing vaccine shortage, they plan to ramp up production to 90 million doses annually by 2026, ensuring that life-saving vaccines are more accessible through flexible pricing.

1 of 1

Story summary

Korean company Eubiologics is stepping up to combat cholera, clinching a $108.3 million deal with UNICEF to supply 72 million vaccines by 2025. In response to a pressing vaccine shortage, they plan to ramp up production to 90 million doses annually by 2026, ensuring that life-saving vaccines are more accessible through flexible pricing.